范科米用于治疗炎症性肠病:除了Clostridioides difficile感染之外还有其作用
Paula Calderón1, Oriana Damas2, Paulina Nuñez3
1Gastroenterología, Clinica Universidad de los Andes, Chile.
Revista espanola de enfermedades digestivas
|October 26, 2023
概括
本案例研究探讨了口服万科米对于难以治愈的克罗恩病 (CD) 病例,这些病例对其他治疗没有反应. 它强调了一种用于治疗炎症性肠病 (IBD) 管理的替代治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 包括生物药物和小分子在内的炎症性肠病 (IBD) 治疗方法已取得显著进展.
- 一个显著的IBD患者小组表现出对现有疗法的初级不响应或二次响应丧失.
- 替代性和新的治疗策略对于管理耐火性IBD病例至关重要.
研究的目的:
- 介绍一个临床案例,详细介绍一个患有复杂克罗恩病 (CD) 的患者的管理.
- 为了评估患者的治疗进化和结果 难以管理的CD治疗口服万科米.
主要方法:
- 使用了临床病例报告方法.
- 该案主要关注一名被诊断患有克罗恩病 (CD) 的患者.
- 治疗涉及口服万科米辛的使用.
主要成果:
- 该案例说明了一个患有挑战性克罗恩病 (CD) 的患者的临床过程.
- 描述了患者在口服万科米辛治疗期间的反应和疾病进展.
- 这突出了耐火性IBD的潜在替代治疗途径.
结论:
- 口服万科米辛可能是选择性炎症性肠病 (IBD) 患者的一种可行的治疗选择.
- 需要进一步研究口服万科米辛在IBD治疗中的有效性和安全性.
- 这个案例有助于理解复杂的CD病例的多样化治疗策略.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
134
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
134
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
Drugs for Treatment of Ulcerative Colitis in IBD
149
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
149
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
122
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
122
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
130
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
130
Inflammatory Bowel Disease V: Surgical Management
149
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
149


